Skip to main content

News

June 15, 2020
Targeted chemo is feasible, safe, and may improve quality of life.
April 16, 2019
Some patients who undergo selective internal radiotherapy (SIRT) with yttrium-90 (Y-90) may be eligible for liver resection, researchers reported.
April 11, 2019
Researchers have identified factors that are linked with increased risk of symptomatic recurrence after radiofrequency ablation for osteoid osteomas.
April 09, 2019
The Society of Interventional Oncology (SIO) recently sent a letter to the National Comprehensive Cancer Network (NCCN) Kidney Cancer Guideline panel seeking changes to proposed guidelines for management of T1a renal masses.
April 04, 2019
In an abstracted presented at SIR, researchers evaluated whether transarterial Y-90 radioembolization with resin microspheres using MIRD dosimetry for intrahepatic cholangiocarcinoma is safe and effective.
March 28, 2019
Patients with metastatic neuroendocrine tumors may potentially be able to consider same-day mapping or no mapping prior to treatment with Y-90 radioembolization, according to an abstract presented at SIR.
March 26, 2019
In an abstract presented at SIR, researchers explained how a review and meta-analysis helps to better understand Y-90 radioembolization dosimetry and how dose relates to tumor response and hepatotoxicity.
March 21, 2019
Researchers used a Markov model to compared liver resection with transarterial chemoembolization (TACE) for cirrhotic patients with resectable intermediate-stage hepatocellular carcinoma.
March 14, 2019
A combined microsphere sizing strategy seemed technically feasible and had a promising toxicity profile and effectiveness measures, researchers reported.
March 12, 2019
Researchers undertook a meta-analysis to determine safety and efficacy of partial nephrectomy versus cryoablation for treatment of patients with T1 renal masses.
March 07, 2019
The researchers undertook the study to better understand oncologic and toxicity outcomes from a combined approach to treatment.
Back to Top